News
Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients ...
A National Science Foundation artificial intelligence institute based at The University of Texas at Austin will receive continued funding for research ...
Apellis Pharmaceuticals won approval from the FDA to expand the use of its drug Empaveli to include treatment for patients ...
FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt
The FDA said it was clearing the way for Sarepta Therapeutics to resume shipments of its gene therapy for Duchenne muscular ...
Apple’s pivot reveals a core truth: real innovation requires knowing whether you’re strength is in being able to dream it, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback